India's pharmaceutical industry has grown by leaps and bounds in the last three decades. The industry has emerged as world's third largest producer of drugs in terms of volume. The industry has posted growth over the last few years, rising to US $36.7 Billion in 2017 and projected to grow to US $55 Billion by 2020, from US $20 billion in 2015.
UBM India is pleased to announce the Pharma Connect Congress slated on the of 12 December 2018 at India Expo Centre, Greater Noida, Delhi NCR.
The key topics that will be discussed at the forum will include, transforming the pharma industry architecture through collaborations, strategies to strengthen regulatory policies in India, efficient clinical trial data management, winning with biosimilars, leveraging latest innovations in technology.
According to Medicine spending in India is expected to increase at 9-12 per cent CAGR between 2018-22 to US$ 26-30 billion, driven by increasing consumer spending, rapid urbanisation, and raising healthcare insurance among others.
The forum will see a congregation of renowned leaders who have headed large pharmaceutical organizations and propelled them to reach new heights of success. Driven by powerful content and unmatched speaker profiles, the forum promises to provide an unique opportunity to bring all key stakeholders in the pharmaceutical industry on a single platform to discuss, deliberate and share their thoughts on achieving the next phase of growth!
Leading figures from the industry to speak at the forum
One-on-one interactions with highly sought after names in the industry
Unprecendented opportunity to grow your business
Single platfom to meet decision makers across leading Indian pharmaceutical giants
Over 250+ attendees
Dr. BM Rao
Vice President and Head of Analytical Science & Technology (ASAT) & Corporate Quality
Dr. Reddy’s Laboratories
Dr. Shubhadeep Sinha
Senior Vice President & Medical Director
Senior Vice President, Clinical Research
Head, Biotechnology R&D
Mankind Pharma Ltd
Dr. Sanjit Singh Lamba
Eisai Pharmaceuticals India
Senior Director - Corporate Affairs
Chief Scientific Officer
Panacea Biotec Ltd
Dr. Ravi Sekhar Kasibhatta
Senior Vice President - Clinical Research
Sanjeev Gupta, Ph.D.
General Manager -Advanced Biotech Lab
Ipca Laboratories Ltd.
Shri Udaya Bhaskar, DG
Dr. Dinesh Dua
Nectar Lifesciences Ltd.
Director, Contract Operations Quality Assurance – Consumer Healthcare, APAC
Ashok Kumar Bhattacharya
Takeda Pharmaceuticals India Pvt. Ltd
Sr. Vice President Formulations R&D
JUBILANT GENERICS LIMITED
Global Leader for Regional and Field Marketing
DuPont Nutrition and Health
IPS Special Commissioner
- Transforming the pharma industry architecture through collaborations
- Strategies to strengthen regulatory policies in India
- Role of digitization in transforming the pharmaceutical sector
- Innovative packaging solutions for the pharmaceutical industry
- Winning with biosimilars
- Leveraging latest innovations in technology
- Sharpen your knowledge base
- Learn from the experts
- Meet key decision makers and influencers
- Understand top trends in the industry
- Extensive networking opportunities
- Single platform to meet top service providers
- Increase your brand presence and visibility
This is a great forum where you can interact, gain knowledge, network and showcase your capabilities as an organization and also learn new trends going around in the market.
This conference had representatives who are stakeholders as well as the policy makers and decision influencers
I look forward from CPhI to see interactions between different parties from the pharmaceutical industry & how collaboration can help all of us to do what we do better
This event is going to help the Indian pharmaceutical industry to understand the challenges and opportunities for the growth in the west accordingly
There is a lot of euphoria in the Industry on this event because not only it offers opportunities for networking with people, it offers opportunities to see what's new, what happening how do we make ourselves more comparative in the industry.